Skip to main content
. 2022 Nov 11;12:19279. doi: 10.1038/s41598-022-23516-y

Table 1.

Medians (25–75th percentiles) values of the laboratory analyses, hemodynamic measures, and clinical and therapy data at each time point for the two groups (septic pigs SS n = 9, sham pigs SH n = 7, if not stated otherwise in the table).

T1 T2 T3 T4 T5
Laboratory analyses
SvO2 SS 57.3 (53,62.8) 46 (42,56.3) 63.5 (61.4,67.9)## 66.6 (62.6,67.2)## 60.3 (59.4,65)#
SH 57 (52.4,61.3) 53 (50,53.8) 56 (50,66.8) 55.1 (52.1,57.8)** 56.7 (53.1,63.5)
Htc SS 0.29 (0.28,0.31)n=8 0.38 (0.36,0.41) 0.29 (0.29,0.31) 0.25 (0.23,0.26)# 0.21 (0.19,0.23)°#§
SH 0.29 (0.26,0.32) 0.28 (0.25,0.30)* 0.23 (0.21,0.23)*° 0.2 (0.16,0.23)*°# 0.21 (0.17,0.27)°§
Hb SS 101 (91,102) 132 (119,141) 100 (94,106) 83 (76,89)# 71 (62,78)°#§
SH 98 (86,106.2) 95 (84.0,98)* 73 (69.8,79)*° 66 (52.5,76.8)*°# 70 (56.5,87)°
Plate SS 276 (244,445)n=8 192 (174,212) 85 (58,94)°# 102 (68,112)° 142 (107,166)
SH 231 (208,306) 193 (158,229) 151 (136,187)*° 174 (156,198)*° 223 (213,237)*§
WBC SS 19.2 (16.2,23.3)n=8 11.7 (9.7,13.1) 11.5 (10.6,17.6) 11.5 (9.6,13.6)° 10.2 (8.3,12.1)°
SH 21.4 (18.6,26.2) 18.3 (13.1,20.8)* 13.8 (11.1,19.2) 13.1 (9.6,14)° 11.9 (10.1,15.4)°
PT SS 13.9 (13.2,14.3)n=8 14.7 (14.6,16.2) 14.7 (14.1,15.1) 14.2 (13.6, 14.7) 14.1 (13.7,14.9)
SH 13.9 (13,14.1) 14.1 (13.8,14.5)* 14.3 (13.2,14.5) 13.5 (13,13.7) 13.7 (13.4,13.7)*
N% SS 5.5 (0.8,14)n=8 48 (38.6,58.6)° 33.5 (26.1,48.8)° 14 (11.5,20)# 6 (1.4,10.2)#§
SH 4 (2.5,12.9) 0 (0,0.5)*° 0 (0,0.9)*° 0.5 (0,1.0)* 0 (0,0.4)*°
Lact SS 0.6 (0.5,0.7) 0.8 (0.7,1.2) 0.8 (0.6,1) 0.7 (0.5,0.9)# 0.4 (0.4,0.8)
SH 0.6 (0.5,0.8) 0.4 (0.4,0.5)* 0.3 (0.3,0.4)* 0.3 (0.2,0.3)*° 0.3 (0.2,0.4)*°
Creat SS 94.0 (86.8, 100.2) 174 (150.8,182.5)° 113 (106.5,165.2) 99 (87.2,112) 89 (80.5,96.2)#§
SH 92 (76.8,100) 106 (98,111.5)* 85 (79.5,97.8)* 86 (65,95.2)# 84 (69.5,86.8)#
Bilirubin SS 1.2 (0.7,1.6) 1.4 (1.1,2.4) 1.5 (1.3,1.9) 1.3 (0.8,2.5) 1.4 (0.9,3.6)
SH 1.1 (0.6,2) 0.9 (0.6,1.6) 0.8 (0.4,1.9) 0.5 (0.3,0.8)* 0.8 (0.3,1.1)
Ammonia SS 51 (36.8,66.5) 107 (72,125.2)n=8° 85 (67,94.5)n=8 78 (61.2,88) 95 (88,114)°
SH 51 (48.2,53.5) 35 (29,36)n=6 42.5 (38,50)n=6 * 43 (40.8,52.8)* 54 (53,66.5)*#§
Hemodynamic variables
SAP SS 103 (94,107) 72 (65,95)° 101 (93,106) 96 (91,102) 97 (96,109)#
SH 103 (97,107) 100 (94,103)* 103 (90,109) 99 (91,106) 99 (94,118)
DAP SS 59.6 (53.2,68.6) 43.8 (34.9,52.7)° 47.5 (44.7,54.1)° 51.1 (48.1,53.9) 57 (50.4,60.5)
SH 59.1 (57.8,64.9) 49.3 (47.4,58.5) 53.3 (43.1,58.9) 54.4 (46.6,57.1) 58.2 (48.3,68)
MAP SS 77.6 (71.1,82.5) 57.9 (46,69.8)° 69.3 (64.6,72.4) 69.8 (67.8,71.5) 76.4 (65.3,77.9)
SH 80.1 (73.2,83.6) 71.1 (68.1,76) 70.5 (64.3,80.7) 73.4 (66.2,77) 78.2 (68.5,89.3)
PP SS 43.0 (35.7,46.9) 32 (29.5,34.4) 49.9 (42.8,55.7)# 46.6 (40.7,51.5)# 48.9 (36.5, 52.6)
SH 44.3 (32.7,46.5) 48.4 (38.4,54.3)* 40.3 (38.0,47.3) 46 (43.3,54.8) 45.5 (41.6,50.5)
HR SS 112 (108,117) 177 (171,214)° 170 (150,176)° 144 (113,150) 115 (105,129)#§
SH 109 (96,114) 86 (81,109)* 72 (62,100)* 65 (51,73)*° 62 (60,66)*°
CVP SS 5.5 (4,6.4)n=8 5.6 (3.1,5.9)n=8 6.3 (3.3,8.5) 7.6 (6.5,9.9)# 10.9 (8,12.1)°#
SH 5.4 (4.2,6.3) 5.9 (4.9,6.6) 8.1 (6.4,9.1) 7.1 (6.6,8.6) 7.2 (6.1,8.6)
CCO SS 4.8 (4.2,5.7)n=8 6.3 (4.4,6.6) 6 (5.6,6.7)° 6.9 (5.9,7.4)°
SH 4.7 (4.6,5.7) 4.7 (4.2,4.8) 4.4 (3.8,6.3) 4.3 (3.5,4.8)* 4.4 (4,5.1)n=6 *
CBF SS 176 (133,204) 108 (101,124) 215 (171,241)# 191 (180,235)# 171 (154,235)#
SH 182 (168,204)n=5 181 (167,187)n=5 * 184 (160,214)n=6 179 (167,195)n=6 185 (148,198)n=6
Global SV SS 42.7 (36.9,48.3)n=8 37.1 (33.5,40.2) 46 (42,50.9) 62 (50,63.8)°§
SH 46.9 (46.2,48.7) 50.7 (44.6,54.7) 64.1 (59.6, 79)*° 68.3 (64.5,73)*° 70 (67.5,77.4)n=6 *°#
Carotid SV SS 1.54 (1.15,1.89) 0.67 (0.52,0.72)° 1.23 (1.16,1.43) 1.47 (1.26,1.7)# 1.68 (1.29,2.09)#
SH 1.77 (1.68,1.94)n=5 2.3 (1.89,2.37)n=5 * 2.74 (2.46,2.90)n=6 * 2.87 (2.59,3.87)n=6 *°# 2.94 (2.51,3.21)n=6
Clinical and therapy data
VP SS 0 (0,0) 0 (0,0) 264.2 (120.9,1503.7) 509.7 (198.4,3181) 595.5 (217.4,4341.5)
SH 0 (0,0) 0 (0,0) 0 (0,9.7)** 0 (0,17.2)** 0 (0,21.1)**
Fluids SS 46 (40.4,51) 59.9 (55.1,64.3) 169 (162.3,177.3) 242.7 (232.5,250.7) 325.5 (284.3,332.5)
SH 60.2 (35,71.4) 74.7 (48.1,83) 149.1 (123.7,168.3) 223.4 (191.8,237.7) 271.3 (249.9,298.3)
Propofol SS 75.7 (63.3,89.4) 160.8 (131.4,176.1) 392 (326.8,411.5) 623.7 (514.7,642.8) 888.4 (739.7,913)
SH 68.4 (59,73.6) 140.6 (120.8,150.5) 367.1 (345.4,371.9) 590.6 (544.7,612.4) 842.5 (804.2,1005.2)
Fentanyl SS 37.6 (34,62.6) 82.6 (63.6,169.1) 210.3 (166.8,442.2) 316.3 (264.6,711.5) 468.6 (401.8,1016.4)
SH 42.7 (35.6,45.9) 80.7 (68.3,87.5) 203.9 (184.8,212.5) 283.7 (273.8,351.3) 399.3 (372.1,468)
UO SS 25.2 (22,31) 32.4 (29.9, 37.4) 58.6 (53.7, 65.9) 87.5 (76.3, 92.5) 103.5 (99.3, 112.5)
SH 27.7 (23.2, 31.9) 37.8 (33.5, 42.5) 68.8 (66.4, 75.6) 102.9 (90.0, 115.8) 142.5 (125.1, 172.5)*
FB SS 19.4 (10.2,28.3) 23 (19.4,32.6) 110.4 (100.4,122.5) 159.4 (150,167.6) 209.7 (181,227.8)
SH 37.4 (9,42.4) 35.7 (12.8,42.2) 79.7 (53.7,98.1) 120.8 (72.7,146.4) 118.1 (66.7,175.6)

SvO2 = mixed venous oxygen saturation [%], Htc = Hematocrit [L/L], Hb = Hemoglobin [g/l], Plat = platelets [109/L], WBC = white blood cells [109/L], PT = prothrombin time [sec], N% = Band neutrophils [%], Lact = lactate [mmol/L], Creat = Creatinine [μmol/L], Bilirubin [μmol/L], Ammonia [μmol/L], SAP = systolic arterial pressure [mmHg], DAP = diastolic arterial pressure [mmHg], MAP = mean arterial pressure [mmHg], PP = pulse pressure [mmHg], HR = heart rate [bpm], CVP = central venous pressure [mmHg], CCO = continuous cardiac output [L/min], CBF = carotid blood flow [mL/min], global SV = global stroke volume [mL], carotid SV = carotid stroke volume [mL], VP = cumulative amount of vasopressors [μg/Kg], Fluids = cumulative fluid input [mL/Kg], cumulative amount of Propofol [mg/Kg], cumulative amount of Fentanyl [µg/Kg], UO = cumulative urine output [mL/Kg], FB = Fluid balance [mL/Kg].

Comparison between Sepsis and Sham: *p-value < 0.05, **p-value < 0.01 (Wilcoxon rank sum test). Wilcoxon signed test: °p < 0.05 with respect to T1, #p < 0.05 with respect to T2, ##p < 0.01 with respect to T2, §p < 0.05 with respect to T3, ^p < 0.05 with respect to T4 (Friedman test p-value < 0.05). The number reported in the apex refers to the number of pigs with available data, if not all.